Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Supplement with SiderAl Med

PreclinicalSmall molecule

FFondazione Policlinico Universitario Agostino Gemelli IRCCS

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Fatigue1 trial

Effects of Nutrition on Post Stroke Fatigue

Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT05728229·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Supplement with SiderAl Med. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Supplement with SiderAl Med compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Supplement with SiderAl Med. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fondazione Policlinico Universitario Agostino Gemelli IRCCS company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: FFondazione Policlinico Universitario Agostino Gemelli IRCCS

Related News